Clearlight — the industry leader in infrared sauna technology — has been selected to provide its Sanctuary 2 infrared saunas for a home-based portion of a clinical research project investigating the relationship between thermoregulation, heat exposure, and Alzheimer's disease resilience. This move follows the publication of a paper in the Journal of Alzheimer's Disease authored by researchers from the University of Montpellier, University of Laval, Washington University, and NYU Grossman School of Medicine.
The study examined an extraordinary case of an individual carrying a genetic mutation strongly associated with early-onset Alzheimer's who — despite showing high amyloid burden — maintained cognitive function and limited tau pathology, with lifelong occupational heat exposure identified as one potential contributing factor warranting further exploration.
Clearlight's saunas were chosen for their ability to deliver controlled, consistent heat exposure within a wellness setting.
Infrared Sauna Research Initiatives
Clearlight Provides Its Sanctuary 2 for Research
Trend Themes
-
Clinical Wellness Validation — Home wellness products with measurable physiological effects are gaining credibility through clinical research partnerships that can transform consumer devices into evidence-linked health platforms.
-
Heat-based Longevity — Thermoregulation and controlled heat exposure are emerging as promising areas of study for cognitive resilience, healthy aging, and preventative wellness applications.
-
At-home Research Tools — Consumer-grade wellness equipment designed for consistent use in residential settings is creating new pathways for decentralized clinical studies and real-world health data collection.
Industry Implications
-
Wellness Technology — Infrared sauna makers and adjacent wellness brands can differentiate through research-grade performance, biomarker integration, and clinically relevant product design.
-
Neurohealth — Alzheimer's research and cognitive health markets may expand around non-pharmaceutical interventions that connect lifestyle exposure, resilience mechanisms, and preventative care models.
-
Clinical Research — Decentralized trial providers and academic institutions are increasingly positioned to incorporate connected home therapies that improve participant access and longitudinal monitoring.